Federal judge rejects $296 million Guidant plea deal
April 27, 2010 by MassDevice staff
A federal judge in Minnesota rejects a guilty plea and $296 million penalty Boston Scientific Corp. would have paid to settle a case against its Guidant Corp. subsidiary over faulty defibrillators.
A federal judge today rejected a $296 million plea agreement between the U.S. Justice Dept. and Boston Scientific Corp. (NYSE:BSX) subsidiary Guidant Corp. over faulty implantable defibrillators.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
Navigation
NEWS
Medtronic hits 52-week high on Q4, FY2013 results
Investors sent Medtronic shares to a 52-week high yesterday after the world's largest medical device...
MassDevice.com +3 | The top 3 med-tech stories for May 21, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Maquet acquires LAAx and its TigerPaw II heart implant
Getinge Group's medical device subsidiary Maquet Cardiovascular buys LAAx and its TigerPaw heart...
EuroPCR: Medtronic's renal denervation looks good in the real world
Medical device giant Medtronic unveils a 1st look from its global Symplicity renal denervation...
Stentys enrolls 1st patient in U.S. stent trial
Stentys launches a clinical trial aimed at backing a pre-market approval application with the FDA for...
